Hasnyálmirigyrák: vizsgálatok itt: Kína
326 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking people68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Peking University Third Hospital
See details and how to joinNCT07760012 - 2. fázisNot yet taking people in KínaIntestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 120
- Run by
- Bing Xia
See details and how to joinNCT07875465 - 1. fázisNot yet taking people in KínaPhase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation
- Where
- Beijing, Hangzhou
- Életkor
- 18 év to 75 év
- People
- 66
- Run by
- Neowise Biotechnology
See details and how to joinNCT07875920 - 2/3. fázisTaking peopleA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Baoding, Beijing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Huzhou, Jinan, Langfang, Lanzhou, Shanghai, Shenzhen, Taiyuan, Wenzhou, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00 - 1. fázisTaking peopleSafety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 167
- Run by
- Shandong Boan Biotechnology Co., Ltd
See details and how to joinNCT06596915 - 2. fázisTaking peopleStereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT07173387 - No phaseTaking peopleNano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 56
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT07408505 - 2. fázisTaking peopleSBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 47
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT07683221 - 3. fázisTaking peopleA Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 201
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07066098 - 1/2. fázisTaking peopleA Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Shanghai, Shenyang, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 222 worldwide
- Run by
- Genfleet Therapeutics (Shanghai) Inc.
See details and how to joinNCT07678593 - 2. fázisTaking peopleA Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 120
- Run by
- Genfleet Therapeutics (Shanghai) Inc.
See details and how to joinNCT07784374 - 2. fázisNot yet taking people in KínaAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Changsha, Chengdu
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 1/2. fázisTaking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Beijing, Shandong
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - 2. fázisTaking peopleLenvatinib Plus Chemotherapy for pNET Liver Metastases
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07835893 - 2. fázisNot yet taking people in KínaSurufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 56
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07833241 - 1/2. fázisTaking peopleStudy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07435038 - 2. fázisNot yet taking people in KínaAlbumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 147
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07828756 - 2/3. fázisTaking peopleA Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
- Where
- Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guandong, Haikou, Hangzhou, Harbin, Hefei, Jinan, Jining, Kunming, Linyi, Nanchang, Nanjing, Nanning, Nantong, Qinhuangdao, Shanghai, Shenyang, Shenzhen, Suzhou, Taiyuan, Tianjin, Wenzhou, Wuhan, Wuxi, Xiamen, Xi’an, Xinxiang, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 502
- Run by
- Hutchmed
See details and how to joinNCT06361888 - 2. fázisNot yet taking people in KínaProtein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 225
- Run by
- Fudan University
See details and how to joinNCT07825753 - No phaseNot yet taking people in KínaFive-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 320
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07796906 - 3. fázisTaking peopleStudy of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
- Where
- Beijing, Binzhou, Changsha, Changzhou, Chengdu, Chongqing, Fuyang, Fuzhou, Guangzhou, Ha’erbin, Hangzhou, Hefei, Jilin City, Jinan, Lanzhou, Meizhou, Nanchang, Nanjing, Nanning, Neimeng, Ningbo, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Yangzhou, Yinchuan, Zhengzhou
- People
- 226
- Run by
- Evopoint Biosciences Inc.
See details and how to joinNCT07823049 - 1. fázisTaking peopleNKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- Peking University
See details and how to joinNCT06134960 - 1. fázisTaking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Guangzhou, Hangzhou, Shanghai, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - 2. fázisNot yet taking people in KínaRetlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 88
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07814859 - 3. fázisNot yet taking people in KínaA Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 320
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07803783